Literature DB >> 20647566

The ADAMTS13 metalloprotease domain: roles of subsites in enzyme activity and specificity.

Rens de Groot1, David A Lane, James T B Crawley.   

Abstract

ADAMTS13 modulates von Willebrand factor (VWF) platelet-tethering function by proteolysis of the Tyr1605-Met1606 bond in the VWF A2 domain. To examine the role of the metalloprotease domain of ADAMTS13 in scissile bond specificity, we identified 3 variable regions (VR1, -2, and -3) in the ADAMTS family metalloprotease domain that flank the active site, which might be important for specificity. Eight composite sequence swaps (to residues in ADAMTS1 or ADAMTS2) and 18 single-point mutants were generated in these VRs and expressed. Swapping VR1 (E184-R193) of ADAMTS13 with that of ADAMTS1 or ADAMTS2 abolished/severely impaired ADAMTS13 function. Kinetic analysis of VR1 point mutants using VWF115 as a short substrate revealed reduced proteolytic function (k(cat)/K(m) reduced by 2- to 10-fold) as a result of D187A, R190A, and R193A substitutions. Analysis of VR2 (F216-V220) revealed a minor importance of this region. Mutants of VR3 (G236-A261) proteolysed wild-type VWF115 normally. However, using either short or full-length VWF substrates containing the P1' M1606A mutation, we identified residues within VR3 (D252-P256) that influence P1' amino acid specificity, we hypothesize, by shaping the S1' pocket. It is concluded that 2 subsites, D187-R193 and D252-P256, in the metalloprotease domain play an important role in cleavage efficiency and site specificity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20647566      PMCID: PMC2974611          DOI: 10.1182/blood-2009-12-258780

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

Authors:  C A Siedlecki; B J Lestini; K K Kottke-Marchant; S J Eppell; D L Wilson; R E Marchant
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

2.  Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.

Authors:  B E Fischer; G Kramer; A Mitterer; L Grillberger; M Reiter; W Mundt; F Dorner; J Eibl
Journal:  Thromb Res       Date:  1996-10-01       Impact factor: 3.944

3.  ADAMTS13 is expressed in hepatic stellate cells.

Authors:  Wenhua Zhou; Mari Inada; Tai-Ping Lee; Daniel Benten; Sergey Lyubsky; Eric E Bouhassira; Sanjeev Gupta; Han-Mou Tsai
Journal:  Lab Invest       Date:  2005-06       Impact factor: 5.662

4.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

5.  Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress.

Authors:  Stefano Lancellotti; Vincenzo De Filippis; Nicola Pozzi; Flora Peyvandi; Roberta Palla; Bianca Rocca; Sergio Rutella; Dario Pitocco; Pier Mannuccio Mannucci; Raimondo De Cristofaro
Journal:  Free Radic Biol Med       Date:  2009-12-04       Impact factor: 7.376

6.  ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.

Authors:  Cynthia M Pruss; Colleen R P Notley; Carol A Hegadorn; Lee A O'Brien; David Lillicrap
Journal:  Br J Haematol       Date:  2008-11       Impact factor: 6.998

7.  A functional calcium-binding site in the metalloprotease domain of ADAMTS13.

Authors:  Michelle D Gardner; Chan K N K Chion; Rens de Groot; Anuja Shah; James T B Crawley; David A Lane
Journal:  Blood       Date:  2008-12-01       Impact factor: 22.113

8.  Molecular characterization of ADAMTS13 gene mutations in Japanese patients with Upshaw-Schulman syndrome.

Authors:  Masanori Matsumoto; Koichi Kokame; Kenji Soejima; Masayoshi Miura; Syuhei Hayashi; Yasuhiko Fujii; Asayuki Iwai; Etsuro Ito; Yoichiro Tsuji; Mayuko Takeda-Shitaka; Mitsuo Iwadate; Hideaki Umeyama; Hideo Yagi; Hiromichi Ishizashi; Fumiaki Banno; Tomohiro Nakagaki; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Blood       Date:  2003-10-16       Impact factor: 22.113

9.  Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.

Authors:  Junmei Chen; Xiaoyun Fu; Yi Wang; Minhua Ling; Brad McMullen; John Kulman; Dominic W Chung; José A López
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

Review 10.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

View more
  14 in total

1.  ADAMTS13 and von Willebrand factor interactions.

Authors:  Catherine B Zander; Wenjing Cao; X Long Zheng
Journal:  Curr Opin Hematol       Date:  2015-09       Impact factor: 3.284

2.  Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.

Authors:  C M Pruss; M Golder; A Bryant; C Hegadorn; S Haberichter; D Lillicrap
Journal:  J Thromb Haemost       Date:  2012-05       Impact factor: 5.824

3.  Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.

Authors:  Nicoletta Sorvillo; Daniella M Mizurini; Carmen Coxon; Kimberly Martinod; Ronak Tilvawala; Deya Cherpokova; Ari J Salinger; Robert J Seward; Caleb Staudinger; Eranthie Weerapana; Nathan I Shapiro; Catherine E Costello; Paul R Thompson; Denisa D Wagner
Journal:  Circ Res       Date:  2019-06-28       Impact factor: 17.367

4.  Conformational activation of ADAMTS13.

Authors:  Kieron South; Brenda M Luken; James T B Crawley; Rebecca Phillips; Mari Thomas; Richard F Collins; Louis Deforche; Karen Vanhoorelbeke; David A Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 5.  ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.

Authors:  Konstantine Halkidis; X Long Zheng
Journal:  J Thromb Haemost       Date:  2022-08-03       Impact factor: 16.036

6.  Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).

Authors:  Yaozu Xiang; Rens de Groot; James T B Crawley; David A Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-24       Impact factor: 11.205

Review 7.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

8.  The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

9.  A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Authors:  Christopher J Lynch; Adam D Cawte; Carolyn M Millar; David Rueda; David A Lane
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

10.  Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity.

Authors:  K South; M O Freitas; D A Lane
Journal:  J Thromb Haemost       Date:  2016-09-23       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.